{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:34:53Z","timestamp":1784334893955,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.bjhh.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T22:31:19Z","timestamp":1496183479000},"page":"252-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms"],"prefix":"10.1016","volume":"39","author":[{"given":"Elissandra Machado","family":"Arlindo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Aydos","family":"Marcondes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavo Beno","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Adolpho Moreira","family":"Faulhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjhh.2017.05.002_bib0140","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"9","key":"10.1016\/j.bjhh.2017.05.002_bib0145","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.bjhh.2017.05.002_bib0150","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1158\/1078-0432.CCR-06-1275","article-title":"Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)","volume":"12","author":"Rodig","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bjhh.2017.05.002_bib0155","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bjhh.2017.05.002_bib0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.bjhh.2017.05.002_bib0165","first-page":"303","article-title":"The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes","volume":"89","author":"Del Giudice","year":"2004","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bjhh.2017.05.002_bib0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cyto.b.21105","article-title":"Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS \u2013 part II \u2013 preanalytical issues","volume":"84","author":"Davis","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"issue":"5","key":"10.1016\/j.bjhh.2017.05.002_bib0175","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1309\/AJCP38XRRUGSQOVC","article-title":"(OX-2 membrane glycoprotein) expression in b cell-derived neoplasms","volume":"134","author":"Dorfman","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.bjhh.2017.05.002_bib0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cyto.b.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry","volume":"86","author":"Sandes","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"10.1016\/j.bjhh.2017.05.002_bib0185","doi-asserted-by":"crossref","first-page":"13551","DOI":"10.18632\/oncotarget.6948","article-title":"Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia","volume":"7","author":"Miao","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bjhh.2017.05.002_bib0190","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.bjhh.2017.05.002_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat","year":"2012","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.bjhh.2017.05.002_bib0200","first-page":"98","article-title":"CD123 (interleukin 3 receptor alpha chain)","volume":"15","author":"Moretti","year":"2001","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"10.1016\/j.bjhh.2017.05.002_bib0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1309\/AJCPRL6XSVFMLH9V","article-title":"Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML","volume":"144","author":"Garc\u00eda-Dabrio","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"13","key":"10.1016\/j.bjhh.2017.05.002_bib0210","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1158\/1078-0432.CCR-16-1904","article-title":"Anti-leukemia efficacy and mechanisms of action of SL-101, a novel anti-CD123 antibody-conjugate, in acute myeloid leukemia","volume":"23","author":"Han","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 2","key":"10.1016\/j.bjhh.2017.05.002_bib0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428194.2011.570820","article-title":"Diagnosis of hairy cell leukemia by flow cytometry","volume":"52","author":"Stetler-Stevenson","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.bjhh.2017.05.002_bib0220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1309\/AJCPKUM9J4IXCWEU","article-title":"Characteristic C.D103, CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders","volume":"136","author":"Venkataraman","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.bjhh.2017.05.002_bib0225","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1309\/AJCP0XQDGKFR0HTW","article-title":"A novel flow cytometric antibody panel for distinguishing Burkitt lymphoma from CD10+ diffuse large B-cell lymphoma","volume":"133","author":"Schniederjan","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.bjhh.2017.05.002_bib0230","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.humpath.2015.01.002","article-title":"CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosis","volume":"46","author":"Ma","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.bjhh.2017.05.002_bib0235","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.1988.tb01476.x","article-title":"Induction of CD43 expression during activation and terminal differentiation of human B cells","volume":"28","author":"Wik\u00e9n","year":"1988","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.bjhh.2017.05.002_bib0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"CAMPATH-1 antigen (CDw52)","volume":"35","author":"Hale","year":"1990","journal-title":"Tissue Antigens"},{"issue":"5","key":"10.1016\/j.bjhh.2017.05.002_bib0245","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.thj.6200119","article-title":"Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies","volume":"2","author":"Rossmann","year":"2001","journal-title":"Hematol J"},{"issue":"4","key":"10.1016\/j.bjhh.2017.05.002_bib0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3816\/CLM.2005.n.016","article-title":"CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment","volume":"5","author":"Owen","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.bjhh.2017.05.002_bib0255","first-page":"1","article-title":"Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia","author":"Vojdeman","year":"2017","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.bjhh.2017.05.002_bib0260","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1440-1827.2006.01986.x","article-title":"Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2","volume":"56","author":"Chuang","year":"2006","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.bjhh.2017.05.002_bib0265","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<236::AID-CYTO4>3.0.CO;2-F","article-title":"U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation","volume":"30","author":"Borowitz","year":"1997","journal-title":"Cytometry"},{"issue":"2","key":"10.1016\/j.bjhh.2017.05.002_bib0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H","article-title":"Terminology and nomenclature for standardization in quantitative fluorescence cytometry","volume":"33","author":"Henderson","year":"1998","journal-title":"Cytometry"}],"container-title":["Revista Brasileira de Hematologia e Hemoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848417300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1516848417300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:23:54Z","timestamp":1602203034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1516848417300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1516848417300713"],"URL":"https:\/\/doi.org\/10.1016\/j.bjhh.2017.05.002","relation":{},"ISSN":["1516-8484"],"issn-type":[{"value":"1516-8484","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Hematologia e Hemoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjhh.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}